Dr. Hönle AG

EANS-News: Hönle Gruppe realises operating profit of Mio. EUR 5.3

--------------------------------------------------------------------------------
  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.
--------------------------------------------------------------------------------
Financial Figures/Balance Sheet


Gräfeling/München (euro adhoc) - In the first nine months of fiscal year
2011/2012, sales of the Hönle Group increased partly due to the consolidation of
new subsidiaries from TEUR 48,036 last year to TEUR 51,725 in the current fiscal
year. The reluctance in the printing area in the run-up to the trade fair Drupa,
and the decline in sales and the value adjustments in the amount of EUR 1.1
million as a result of the insolvency of Manroland had a negative effect on
business of the Hönle Group. The result was therefore under the previous year's
level. The Hönle Group generated in the first nine months an operating profit
(EBIT) of TEUR 5,316 (PY: TEUR 7,642). Pre-tax earnings (EBT) amounted to TEUR
4,961, after TEUR 7,364 in the previous year, consolidated net income fell to
TEUR 3,285 from TEUR 5,186 in the previous year. This corresponds to earnings
per share of EUR 0.55 (PY: EUR 0.92).

After 15.9% in the previous year the EBIT margin amounted to 10.3% in the
current year, the net profit margin decreased from 10.8% to 6.4%. The operating
cash flow amounted to TEUR 4,569 in the current fiscal year, after TEUR 8,134 in
the previous year. The Hönle Group's equity capital ratio stood at 59.4%.

Outlook:
The Management Board aims at achieving sales revenues of more than EUR 70
million and an operating result of EUR 8 million for the Hönle Group in the
2011/2012 financial year.

Hönle has weathered the impact of the Manroland insolvency good and due to the
restructuring created the basis to realize future earnings level in the sheetfed
sector at the level of the previous year.
Hönle presented this year to focus on the successful structural alignment of all
companies in the Hönle Group, in particular the Raesch group, UV-Technik
Speziallampen GmbH and Mitronic GmbH. Thereby Hönle created the conditions, to
grow in existing as well as new markets and to increase sales with short-lived
goods by strengthening the segment 'Glass and Lamps'.

Provided that the general economic conditions do not deteriorate significantly,
the Hönle Group perceives good opportunities to exceed the sales threshold of
EUR 100 million in the next three years. The aim is to achieve thereby an EBIT
ratio of 14% to 16%.



About Hönle: 
Dr. Hönle AG is a listed technology company with head office in Gräfelfing near
Munich. With a staff level of nearly 500 employees, the Hönle Group is one of
the world's leading systems suppliers in the UV technology segment. The
equipment is used for drying inks and coatings, curing adhesives and plastics,
disinfecting surfaces, and for the simulation of natural sunlight. The Company's
business activities focus also on the development and sale of industrial
adhesives and casting compounds. In addition, the group produces UV lamps
particularly for water disinfection and manufactures tubes and semi-finished
products made of quartz glass, which are used in different branches of industry.
The Group is represented worldwide at 50 locations in more than 20 countries by
own companies and sales partners.


Further inquiry note:
Peter Weinert
Tel.: +49 89 85608 173
E-Mail: peter.weinert@hoenle.de
Web: www.hoenle.de

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


company:     Dr. Hönle AG
             Lochhamer Schlag  1
             D-82166 Gräfeling/München
phone:       +49 89 85608 0
FAX:         +49 89 85608 101
mail:     ir@hoenle.de
WWW:      www.hoenle.de
sector:      Instrument Engineering
ISIN:        DE0005157101
indexes:     CDAX, Prime All Share, Technology All Share
stockmarkets: free trade: Hannover, Berlin, München, Hamburg, Düsseldorf,
             Stuttgart, regulated dealing/prime standard: Frankfurt 
language:   English
 



Weitere Meldungen: Dr. Hönle AG

Das könnte Sie auch interessieren: